| Revumenib studied in …STUDIED_INderived26 of 26show fewer |
|---|
| → studied in | NCT07211958Phase 3 · recruiting Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation · 26 trials list this drug (20 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05360160Phase 1/Phase 2 · recruiting A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE) · 26 trials list this drug (20 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07052994Phase 1 · withdrawn A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients · 26 trials list this drug (20 active) | — | — | Childhood Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06284486Phase 1/Phase 2 · recruiting A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib · 26 trials list this drug (20 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04065399Phase 1/Phase 2 · recruiting A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation · 26 trials list this drug (20 active) | — | — | Acute Lymphoblastic Leukemia,Acute Leukemia of Ambiguous Lineage,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06226571Phase 1 · active not recruiting A Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias · 26 trials list this drug (20 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06229912Phase 2 · recruiting A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes · 26 trials list this drug (20 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07605949Phase 2 · not yet recruiting Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML · 26 trials list this drug (20 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03013998Phase 2/Phase 3 · recruiting Study of Biomarker-Based Treatment of Acute Myeloid Leukemia · 26 trials list this drug (20 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06652438Phase 3 · recruiting Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML · 26 trials list this drug (20 active) | — | — | Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05761171Phase 2 · active not recruiting A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia · 26 trials list this drug (20 active) | — | — | Acute Lymphoblastic Leukemia,Acute Leukemia of Ambiguous Lineage,Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05886049Phase 1 · recruiting A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease · 26 trials list this drug (20 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with KMT2A Rearrangement+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07283640Phase 1 · not yet recruiting A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia · 26 trials list this drug (20 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06177067Phase 1 · recruiting Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia · 26 trials list this drug (20 active) | — | — | Acute Leukemia of Ambiguous Lineage,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07686107Phase 2 · not yet recruiting Trial of Revumenib Plus FLA Chemotherapy for Children With Relapsed or Refractory NUP98-rearranged AML." · 26 trials list this drug (20 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05731947Phase 1/Phase 2 · terminated Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors · 26 trials list this drug (20 active) | — | — | Solid Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07356154Phase 1/Phase 2 · recruiting A Study of Revumenib and Mezigdomide in People With Leukemia · 26 trials list this drug (20 active) | — | — | Leukemia,Acute Leukemia,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07563010Phase 2 · not yet recruiting Menin-Inhibitor Targeted Maintenance in AML · 26 trials list this drug (20 active) | — | — | Transplant-Related Hematologic Malignancy,Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636564Phase 2 · not yet recruiting Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment · 26 trials list this drug (20 active) | — | — | Acute Leukemia of Ambiguous Lineage,B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06222580Phase 1 · recruiting SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation · 26 trials list this drug (20 active) | — | — | Acute Myeloid Leukemia,Acute Myeloid Leukemia with KMT2A Rearrangement,Acute Myeloid Leukemia with NPM1 Mutation+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07498465Phase 1 · withdrawn A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia · 26 trials list this drug (20 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia,Childhood Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06313437Phase 1 · recruiting Revumenib in Combination With 7+3 + Midostaurin in AML · 26 trials list this drug (20 active) | — | — | Leukemia,Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06575296Phase 1 · recruiting Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant · 26 trials list this drug (20 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Acute Leukemia of Ambiguous Lineage+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05918913no longer available Expanded Access Program for Revumenib · 26 trials list this drug (20 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05406817Phase 1 · completed Study of Radiolabeled Revumenib in Adults With Acute Leukemia · 26 trials list this drug (20 active) | — | — | Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05326516Phase 1 · completed A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia · 26 trials list this drug (20 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia,Acute Undifferentiated Leukemia+1 | 1 | Observed | clinicaltrials | graph → |